Human HLA class II-restricted CD4+ T-cell receptor recognizing Coxiella burnetii epitopes (C. burnetii-specific CD4+ TCR)

Human HLA class II-restricted CD4+ T-cell receptors (TCRs) recognizing Coxiella burnetii epitopes are specialized protein complexes found on the surface of helper T cells that play a pivotal role in the immune response against Q fever. These TCRs are responsible for the specific recognition of processed peptides derived from Coxiella burnetii, an obligate intracellular bacterium, when these peptides are displayed by Human Leukocyte Antigen (HLA) class II molecules on the surface of professional antigen-presenting cells (Long et al., 2022). The interaction between the TCR and the peptide-MHC II complex initiates a signaling cascade that activates the CD4+ T cell, leading to the production of critical cytokines such as interferon-gamma (IFN-γ). This cytokine production is essential for activating macrophages to kill the intracellular bacteria and orchestrating the broader adaptive immune response (Schoenlaub et al., 2015). In the context of disease, these receptors are central to both the clearance of acute infection and the prevention of chronic Q fever, which can manifest as life-threatening endocarditis (Moosavian et al., 2021). While there are no direct small-molecule drugs for these TCRs, they are the primary focus for the development of next-generation subunit vaccines and diagnostic tools. For example, interferon-gamma release assays (IGRAs) utilize these TCR-mediated responses to assess cellular immunity in exposed individuals (Roest et al., 2011). Therapeutic strategies involving these TCRs often focus on identifying immunodominant epitopes to enhance vaccine-induced protection or exploring adoptive T-cell transfer for persistent infections. Safety concerns in targeting these receptors include potential cross-reactivity with self-antigens, which could lead to autoimmune complications. Understanding the diversity of these TCRs across different HLA backgrounds is crucial for ensuring broad population coverage in vaccine design.

Other names

Coxiella burnetii-specific T-cell receptorQ fever-specific TCRHLA-II restricted CD4+ TCRC. burnetii-reactive TCR

Activation of CD4+ T-lymphocytes through the recognition of specific bacterial peptides presented by HLA class II molecules, leading to cytokine release and macrophage activation.